Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2002-8-14
pubmed:abstractText
To compare the efficacy and tolerability of fulvestrant (formerly ICI 182,780) with anastrozole in the treatment of advanced breast cancer in patients whose disease progresses on prior endocrine treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3386-95
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12177098-Adult, pubmed-meshheading:12177098-Aged, pubmed-meshheading:12177098-Aged, 80 and over, pubmed-meshheading:12177098-Antineoplastic Agents, Hormonal, pubmed-meshheading:12177098-Breast Neoplasms, pubmed-meshheading:12177098-Disease-Free Survival, pubmed-meshheading:12177098-Double-Blind Method, pubmed-meshheading:12177098-Estradiol, pubmed-meshheading:12177098-Estrogen Antagonists, pubmed-meshheading:12177098-Female, pubmed-meshheading:12177098-Humans, pubmed-meshheading:12177098-Middle Aged, pubmed-meshheading:12177098-Neoplasm Metastasis, pubmed-meshheading:12177098-Nitriles, pubmed-meshheading:12177098-North America, pubmed-meshheading:12177098-Postmenopause, pubmed-meshheading:12177098-Quality of Life, pubmed-meshheading:12177098-Survival Rate, pubmed-meshheading:12177098-Triazoles
pubmed:year
2002
pubmed:articleTitle
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
pubmed:affiliation
Breast Center at Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA. kosborne@breastcenter.tmc.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III